Patient age affects the growth of liver haemangioma
نویسندگان
چکیده
منابع مشابه
Enucleation for Giant Liver Haemangioma
67 quantitative measures of liver function remained good. These data are consistent with our own study comparing DSRS and sclerotherapy which measured quantitative liver function. We showed that patients successfully managed with sclerotherapy, who had no major rebleeding, showed a significant improvement in galactose elimination capacity over the first year1. Lesson: the data in this study sho...
متن کاملan investigation about the relationship between insurance lines and economic growth; the case study of iran
مطالعات قبلی بازار بیمه را به صورت کلی در نظر می گرفتند اما در این مطالعه صنعت بیمه به عنوان متغیر مستفل به بیمه های زندگی و غیر زندگی شکسته شده و هم چنین بیمه های زندگی به رشته های مختلف بیمه ای که در بازار بیمه ایران سهم قابل توجهی دارند تقسیم میشود. با استفاده از روشهای اقتصاد سنجی داده های برای دوره های 48-89 از مراکز ملی داده جمع آوری شد سپس با تخمین مدل خود بازگشتی برداری همراه با تعدادی ...
15 صفحه اولSuccessful Arterial Embolisation of Giant Liver Haemangioma
A 28-year old man presented with a symptomatic giant haemangioma. On June 26, 1983, at laparotomy, no resection was attempted because the lesion involved the right lobe of the liver and a part of segments II and III. The patient underwent a right hepatic arterial embolisation with gelatine sponge particles. During follow-up, the patient remained asymptomatic. Five-year review by CT-scan showed ...
متن کاملGiant haemangioma of the liver: observation or resection?
BACKGROUND Haemangiomata are the most frequent benign solid liver lesion. The management of giant (> or =5 cm) haemangiomata of the liver remains controversial. METHODS A search of relevant peer-reviewed literature was conducted using PubMed and original articles were reviewed. RESULTS AND CONCLUSIONS The vast majority of giant haemangiomata remain asymptomatic and have a benign and uncompl...
متن کاملRadiation therapy in cavernous haemangioma of the liver.
Cavernous haemangioma (CHL) is the commonest benign tumour of the liver. It was first described in 1861 by Frerichs and later by others. CHL of the liver are common in females and can occur at any age. The majority of these tumours are small, asymptomatic and without clinical significance. Large tumours might cause symptoms and require treatment. The symptoms can be non-specific and diagnosis d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: HPB
سال: 2018
ISSN: 1365-182X
DOI: 10.1016/j.hpb.2017.08.021